Balanced news tone
News Sentiment
NOVOBN sentiment intelligence
Novo Nordisk A/S news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
40
Balanced news tone
15 relevant articles
News tone and price action are not far from neutral.
88/100 classification confidence.
directly relevant articles
high-authority source matches
+2.8% over one week, -1.5% over four weeks, trend inactive, and below fair value.
Novo Nordisk: A Fallen Leader Trading At Fair Value, Not A Bargain (NYSE:NVO)
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
88/100 classification
One-week reaction
2.8%
Price confirming higher
Trend fit
Trend inactive
-1.5% over four weeks
Fair value
-50.6%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
2
Neutral
6
Negative
7
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Seeking Alpha
Direct company coverage
Novo Nordisk: A Fallen Leader Trading At Fair Value, Not A Bargain (NYSE:NVO)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 07:39
- Source
- Seeking Alpha
AD HOC NEWS
Direct company coverage
Novo Nordisk A/S stock (DK0062498333): Wegovy momentum, Q1 figures and diabetes focus
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- AD HOC NEWS
Investing.com
Direct company coverage
Novo Nordisk lifts 2026 outlook as Wegovy drives growth; shares jump
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 06 May 2026 07:00
- Source
- Investing.com
Seeking Alpha
Direct company coverage
Novo Nordisk's Weight Loss Doesn't Mean To Load Up (NYSE:NVO)
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 15 Apr 2026 07:00
- Source
- Seeking Alpha
Barchart
Direct company coverage
Novo Nordisk Just Announced Wegovy Subscriptions. Does That Make NVO Stock a Buy?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Apr 2026 07:00
- Source
- Barchart
Investing.com
Direct company coverage
Novo Nordisk stock falls after FDA warning letter
- Tone
- Negative 6/100
- Event
- Market update
- Published
- 10 Mar 2026 07:00
- Source
- Investing.com
24/7 Wall St.
Direct company coverage
Here Are Monday’s Top Wall Street Analyst Research Calls: AppLovin, Blue Owl Capital, CrowdStrike, Dutch Bros., Jet Blue, Novo Nordisk, PayPal, Twilio, and More
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 02 Mar 2026 08:00
- Source
- 24/7 Wall St.
Reuters
Direct company coverage
Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Feb 2026 08:00
- Source
- Reuters
Law Commentary
Direct company coverage
Novo Nordisk Files Patent Lawsuit Against Hims & Hers Over Compounded Semaglutide Products
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 10 Feb 2026 08:00
- Source
- Law Commentary
Investing.com
Direct company coverage
Novo Nordisk shares fall 18% amid lower 2026 sales outlook
- Tone
- Negative 6/100
- Event
- Guidance
- Published
- 03 Feb 2026 08:00
- Source
- Investing.com
Investing.com
Direct company coverage
Novo Nordisk stock soars after FDA approves first oral GLP-1 for weight loss
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 22 Dec 2025 08:00
- Source
- Investing.com
Reuters
Direct company coverage
Novo Nordisk's weight-loss challenge in five charts
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Nov 2025 08:00
- Source
- Reuters
Reuters
Direct company coverage
Novo Nordisk shares fall as top investor drives board overhaul
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 22 Oct 2025 07:00
- Source
- Reuters
Reuters
Direct company coverage
Shares in Novo Nordisk rise after Wegovy gets US nod for liver disease treatment
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Aug 2025 07:00
- Source
- Reuters
Reuters
Direct company coverage
Novo Nordisk shares fall as obesity pipeline faces investor scrutiny
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 23 Jun 2025 07:00
- Source
- Reuters